1. Au III Acyclic (Amino)(N-Pyridinium)carbenoids: Synthesis via Addition of 2-PySeCl to Au I -Bound Isonitriles, Structures, and Cytotoxicity.
- Author
-
Repina OV, Kubasov AS, Vologzhanina AV, Borisov AV, Kritchenkov IS, Voroshilkina KM, Nazarov AA, Shchevnikov DM, Grudova MV, Gomila RM, Frontera A, Nenajdenko VG, Kritchenkov AS, and Tskhovrebov AG
- Subjects
- Humans, Cell Line, Tumor, Pyridinium Compounds chemistry, Pyridinium Compounds pharmacology, Pyridinium Compounds chemical synthesis, Density Functional Theory, Molecular Structure, Pyridines chemistry, Pyridines pharmacology, Coordination Complexes chemistry, Coordination Complexes pharmacology, Coordination Complexes chemical synthesis, Crystallography, X-Ray, Gold chemistry, Antineoplastic Agents pharmacology, Antineoplastic Agents chemistry, Antineoplastic Agents chemical synthesis, Nitriles chemistry, Nitriles pharmacology
- Abstract
In this study, we report the first example of acyclic (amino)(N-pyridinium)carbenoid gold(III) complexes synthesized via a coupling reaction between 2-pyridylselenyl chloride and Au(I)-bound isonitriles. The reaction involves an initial oxidative addition of the Se-Cl moiety to Au(I), followed by the nucleophilic addition of the pyridine fragment to the isonitrile's C≡N bond, furnishing a metallacycle. Importantly, this is the first example of the pyridine acting as a nucleophile towards metal-bound isonitriles. Arguably, such an addition is due to the chelate effect. The structures of the gold(III) carbenoid complexes were unambiguously established using X-ray diffraction and NMR spectroscopy. Theoretical calculations, including DFT, Natural Resonance Theory (NRT), and Meyer bond order (MBO) analyses, were used to analyze the different resonance forms. The reaction mechanism was further elucidated using DFT calculations, which identified the oxidative addition as the rate-determining step with a barrier of 29.7 kcal/mol. The nucleophilic addition proceeds with a minimal barrier, making the reaction highly favorable. The antiproliferative activity of new compounds 2a - 2e was tested against two human cancer cell lines: A2780 ovarian adenocarcinoma and the A278Cis cisplatin-resistant variant.
- Published
- 2025
- Full Text
- View/download PDF